Some Improvement in Post-ACS Outcomes with Adjunctive Ezetimibe (FREE)

By Harlan M. Krumholz, MD, SM Dr. Krumholz is Editor-in-Chief of NEJM Journal Watch Cardiology, from which this story was adapted. See full coverage at the link below.Ezetimibe plus simvastatin is associated with better outcomes at 7 years than statin monotherapy, according to a New England …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news